Rouan Sarah Kathryn
- SEC CIK
- 0001761366
No open-market purchases or sales filed in the past year.
Current role at each company
- VKTX Viking Therapeutics, Inc.Directoras of Jan 5, 2026
- NAVB Navidea Biopharmaceuticals, Inc.Directoras of Jul 7, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rouan Sarah Kathryn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VKTX Viking Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2025 (view filing) | Mar 31 | 8 days | Rouan Sarah KathrynDirector | PPurchaseCommon Stock, par value $0.00001 per share | +1.24K | $24.15 | +$29.9K | New position1.24K after | Amended |
| Oct 25, 2024 (view filing) | Oct 25 | Same day | Rouan Sarah KathrynDirector | SSaleCommon Stock, par value $0.00001 per share | −11.0K | $80.89 | −$889.8K | −100.0%0 after | 10b5-1 |
| Feb 8, 2024 (view filing) | Feb 8 | Same day | Rouan Sarah KathrynDirector | SSaleCommon Stock, par value $0.00001 per share | −25.0K | $28.05 | −$701.3K | −100.0%0 after | 10b5-1 |
| Jan 19, 2024 (view filing) | Jan 19 | Same day | Rouan Sarah KathrynDirector | SSaleCommon Stock, par value $0.00001 per share | −30.0K | $23.05 | −$691.5K | −100.0%0 after | 10b5-1 |